Matthew B. Murphy insider trades
Open-market stock purchases and sales by Matthew B. Murphy, General Counsel at Nautilus Biotechnology, Inc, from SEC Form 4 filings since Jun 14, 2021.
Track record: 25% of 4 scored buys are up 5% or more since purchase, averaging +43%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 2, 2026 | NAUT Nautilus Biotechnology, Inc | Bought (not open market) | — |
Companies traded
- NAUT Nautilus Biotechnology, Inc: 4 buys, last Mar 2, 2026